Unique ID issued by UMIN | UMIN000030735 |
---|---|
Receipt number | R000034581 |
Scientific Title | Diagnostic accuracy of contrast enhanced endoscopic ultrasonography in pancreatbiliary disease |
Date of disclosure of the study information | 2018/01/15 |
Last modified on | 2019/07/12 10:09:40 |
Diagnostic accuracy of contrast enhanced endoscopic ultrasonography in pancreatbiliary disease
A clinical trial of contrast enhanced endoscopic ultrasonography in the pancreatobiliary disease
Diagnostic accuracy of contrast enhanced endoscopic ultrasonography in pancreatbiliary disease
A clinical trial of contrast enhanced endoscopic ultrasonography in the pancreatobiliary disease
Japan |
Pancreas tumor, Chronic pancreatitis, Autoimmune pancreatitis, Gallblader polyp, Biliary tract tumor
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The aim of the present study is to evaluate whether contrast-enhanced endoscopic ultrasonography can provide a reliable diagnosis for pancreatobbiliary disease.
Efficacy
To evaluate whether contrast enhanced endoscopic ultrasonography can provide a reliable diagnosis for pancreatobbiliary disease, we compare the diagnostic accuracy of contrast enhanced endoscopic ultrasonography with enhanced conputed tomography, magnetic resonance imaging, and endoscopic ultrasonography without perflubutane
Interventional
Parallel
Non-randomized
Double blind -all involved are blinded
Active
4
Diagnosis
Medicine |
Contrast enhanced endoscopic ultrasonography using perflubutane
MRI
enhanced CT
endoscopic ultrasonography without perflubutane
20 | years-old | <= |
100 | years-old | >= |
Male and Female
1.Patients who are suspected pacreatobiliary disease by ohter modality(CT, US, MRI).
2.Performance status; 0,1,2.
3.Patients who got ingormed consent.
1.Patients with allergy to egg.
2.Patients with arteriovenous shunt in cardia.
3.Patients woth severe cardiac disease.
4.Patients with sebere lung disorder.
5.Female patients with pregnacy or nursing.
6.Patients with mental aliments who cannot sign up for this clinical trial.
7.Patients with adverse events to perflubutane including minimal side effects.
8.Inadequate patients to participate in this study, in the judgement of an attending doctor or inspection physician.
786
1st name | |
Middle name | |
Last name | Kazuki Sumiyama |
The Jikei University School of Medicine
Department of Endoscopy
3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan
0334331111
kaz_sum@jikei.ac.jp
1st name | |
Middle name | |
Last name | Masafumi Chiba |
The Jikei University School of Medicine
Department of Endoscopy
3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, Japan
0334331111
ccl09720@gmail.com
Department of Endoscopy
The Jikei University School of Medicine
Department of Endoscopy
The Jikei University School of Medicine
Self funding
NO
東京慈恵会医科大学附属病院(東京都)、東京慈恵会医科大学附属柏病院(千葉県)、東京慈恵会医科大学葛飾医療センター(東京都)、東京慈恵会医科大学附属第三病院(東京都)
2018 | Year | 01 | Month | 15 | Day |
Unpublished
Completed
2017 | Year | 11 | Month | 14 | Day |
2018 | Year | 11 | Month | 14 | Day |
2018 | Year | 01 | Month | 15 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2018 | Year | 01 | Month | 09 | Day |
2019 | Year | 07 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034581